BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36178355)

  • 1. Active Surveillance of Papillary Thyroid Cancer: Frequency and Time Course of the Six Most Common Tumor Volume Kinetic Patterns.
    Tuttle RM; Fagin J; Minkowitz G; Wong R; Roman B; Patel S; Untch B; Ganly I; Shaha A; Shah J; Li D; Bach A; Girshman J; Lin O; Cohen M; Cohen JM; Cracchiolo J; Ghossein R; Sabra M; Boucai L; Fish S; Morris L
    Thyroid; 2022 Nov; 32(11):1337-1345. PubMed ID: 36178355
    [No Abstract]   [Full Text] [Related]  

  • 2. Natural History and Tumor Volume Kinetics of Papillary Thyroid Cancers During Active Surveillance.
    Tuttle RM; Fagin JA; Minkowitz G; Wong RJ; Roman B; Patel S; Untch B; Ganly I; Shaha AR; Shah JP; Pace M; Li D; Bach A; Lin O; Whiting A; Ghossein R; Landa I; Sabra M; Boucai L; Fish S; Morris LGT
    JAMA Otolaryngol Head Neck Surg; 2017 Oct; 143(10):1015-1020. PubMed ID: 28859191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of papillary thyroid microcarcinoma: Kinetic analyses on tumor volume during active surveillance and before presentation.
    Miyauchi A; Kudo T; Ito Y; Oda H; Yamamoto M; Sasai H; Higashiyama T; Masuoka H; Fukushima M; Kihara M; Miya A
    Surgery; 2019 Jan; 165(1):25-30. PubMed ID: 30413323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applying Criteria of Active Surveillance to Low-Risk Papillary Thyroid Cancer Over a Decade: How Many Surgeries and Complications Can Be Avoided?
    Griffin A; Brito JP; Bahl M; Hoang JK
    Thyroid; 2017 Apr; 27(4):518-523. PubMed ID: 28125944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor Volume Doubling Time in Active Surveillance of Papillary Thyroid Carcinoma.
    Oh HS; Kwon H; Song E; Jeon MJ; Kim TY; Lee JH; Kim WB; Shong YK; Chung KW; Baek JH; Kim WG
    Thyroid; 2019 May; 29(5):642-649. PubMed ID: 30864894
    [No Abstract]   [Full Text] [Related]  

  • 6. Active Surveillance for Patients With Papillary Thyroid Microcarcinoma: A Single Center's Experience in Korea.
    Kwon H; Oh HS; Kim M; Park S; Jeon MJ; Kim WG; Kim WB; Shong YK; Song DE; Baek JH; Chung KW; Kim TY
    J Clin Endocrinol Metab; 2017 Jun; 102(6):1917-1925. PubMed ID: 28323932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active surveillance in papillary thyroid carcinoma: not easily accepted but possible in Latin America.
    Smulever A; Pitoia F
    Arch Endocrinol Metab; 2019; 63(5):462-469. PubMed ID: 31482955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommend with caution: A meta-analysis investigating papillary thyroid carcinoma tumor progression under active surveillance.
    Issa PP; Munshi R; Albuck AL; Omar M; Abu Alhuda RF; Metz T; Hussein M; Shama M; Lee GS; Toraih E; Kandil E
    Am J Otolaryngol; 2023; 44(6):103994. PubMed ID: 37607459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Patient Age With Progression of Low-risk Papillary Thyroid Carcinoma Under Active Surveillance: A Systematic Review and Meta-analysis.
    Koshkina A; Fazelzad R; Sugitani I; Miyauchi A; Thabane L; Goldstein DP; Ghai S; Sawka AM
    JAMA Otolaryngol Head Neck Surg; 2020 Jun; 146(6):552-560. PubMed ID: 32297926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality Risk of Nonoperative Papillary Thyroid Carcinoma: A Corollary for Active Surveillance.
    Ho AS; Luu M; Zalt C; Morris LGT; Chen I; Melany M; Ali N; Patio C; Chen Y; Mallen St-Clair J; Braunstein GD; Sacks WL; Zumsteg ZS
    Thyroid; 2019 Oct; 29(10):1409-1417. PubMed ID: 31407637
    [No Abstract]   [Full Text] [Related]  

  • 11. Marked Decrease Over Time in Conversion Surgery After Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma.
    Sasaki T; Miyauchi A; Ito Y; Kudo T; Kanemura N; Sano T; Kawano S; Yamamoto M; Fujishima M; Masuoka H; Higashiyama T; Kihara M; Miya A
    Thyroid; 2021 Feb; 31(2):217-223. PubMed ID: 32664805
    [No Abstract]   [Full Text] [Related]  

  • 12. Serial Neck Ultrasonographic Evaluation of Changes in Papillary Thyroid Carcinoma During Pregnancy.
    Oh HS; Kim WG; Park S; Kim M; Kwon H; Jeon MJ; Lee JH; Baek JH; Song DE; Kim TY; Shong YK; Kim WB
    Thyroid; 2017 Jun; 27(6):773-777. PubMed ID: 28446078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic Analysis of Growth Activity in Enlarging Papillary Thyroid Microcarcinomas.
    Ito Y; Miyauchi A; Kudo T; Higashiyama T; Masuoka H; Kihara M; Miya A
    Thyroid; 2019 Dec; 29(12):1765-1773. PubMed ID: 31650907
    [No Abstract]   [Full Text] [Related]  

  • 14. Active Surveillance for Small Papillary Thyroid Cancer: A Systematic Review and Meta-Analysis.
    Cho SJ; Suh CH; Baek JH; Chung SR; Choi YJ; Chung KW; Shong YK; Lee JH
    Thyroid; 2019 Oct; 29(10):1399-1408. PubMed ID: 31368412
    [No Abstract]   [Full Text] [Related]  

  • 15. Active Surveillance of Small Metastatic Lymph Nodes as an Alternative to Surgery in Selected Patients with Low-Risk Papillary Thyroid Cancer: A Retrospective Cohort Study.
    Jerkovich F; Abelleira E; Bueno F; Guerrero L; Pitoia F
    Thyroid; 2022 Oct; 32(10):1178-1183. PubMed ID: 35876426
    [No Abstract]   [Full Text] [Related]  

  • 16. Tumor Volume Doubling Time in Active Surveillance of Papillary Thyroid Microcarcinoma: A Multicenter Cohort Study in Korea.
    Jin M; Kim HI; Ha J; Jeon MJ; Kim WG; Lim DJ; Kim TY; Chung JH; Shong YK; Kim TH; Kim WB
    Thyroid; 2021 Oct; 31(10):1494-1501. PubMed ID: 34225475
    [No Abstract]   [Full Text] [Related]  

  • 17. Tumor volume-doubling rate is negatively associated with patient age in papillary thyroid microcarcinomas under active surveillance.
    Yamamoto M; Miyauchi A; Ito Y; Fujishima M; Sasaki T; Kudo T
    Surgery; 2024 Apr; 175(4):1089-1094. PubMed ID: 38142143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with Active Surveillance of Thyroid Low-Risk Carcinoma in a Developing Country.
    Sanabria A
    Thyroid; 2020 Jul; 30(7):985-991. PubMed ID: 31950887
    [No Abstract]   [Full Text] [Related]  

  • 19. Interobserver Reproducibility in Sonographic Measurement of Diameter and Volume of Papillary Thyroid Microcarcinoma.
    Chung SR; Choi YJ; Lee SS; Kim SO; Lee SA; Jeon MJ; Kim WG; Lee JH; Baek JH
    Thyroid; 2021 Mar; 31(3):452-458. PubMed ID: 33287640
    [No Abstract]   [Full Text] [Related]  

  • 20. Outcomes of nonsuspicious contralateral nodules with active surveillance after lobectomy in patients with papillary thyroid carcinoma.
    Huang H; Liu J; Wang X; Liu S
    Front Endocrinol (Lausanne); 2022; 13():941080. PubMed ID: 35909520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.